Clinical Trial Update: Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution

View source ↗

Summary

A completed clinical trial evaluating biomarker and thrombogenicity assessment during cardiopulmonary bypass with acute normovolemic hemodilution for bleeding r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding

Snippet

Sponsor: Inova Health Care Services | Conditions: Bleeding Reduction | Status: COMPLETED | Results posted: 2020-01-13